Generic Pharmaceuticals Company Equity Stake For Sale in Palghar, India

Our portfolio spans the full spectrum of pharmaceutical development, from oral dosage forms and semi‑solid formulations to sterile injectables, all supported by commercial supply capabilities. We are also advancing the development of niche APIs, leveraging our expertise to address high‑value therapeutic segments. Beyond manufacturing, we provide regulatory and quality consultancy services that enable organizations to secure advanced market approvals, drawing on our proven track record of over 125 marketing authorizations worldwide, including more than 50 in regulated markets outside the U. S. Our products are already trusted by premium pharmaceutical companies across Europe, the UK, Australia, and New Zealand. - Our asset base reflects both robust infrastructure and unique regulatory strengths. On the tangible side, we operate a dedicated R&D centre, two advanced manufacturing units, and a state-of-the-art sterile drug testing facility. These are complemented by prime real estate holdings, including an office valued at INR 2 crore, a development centre worth INR 25 crore, and a strategically located manufacturing plant in the Phalghar district (MIDC, Tarapur) valued at INR 40 crore.
- Beyond physical assets, our intangible strengths are equally compelling: with over 125 marketing authorizations approved worldwide, we bring leading regulatory expertise that enables us to transform organizations from non-regulated operations into fully compliant, globally recognized businesses. Together, this combination of tangible infrastructure and intangible regulatory leadership positions us to scale rapidly, attract strategic partnerships, and deliver sustainable growth in regulated markets. We have established one of the largest CRO infrastructures in its category, anchored by a fully owned 40,000 sq. ft. development center in Navi Mumbai (HQ) dedicated to generic drug development. The company is registered in Navi Mumbai.
Complementing this is a strategically located 1,500 sq. ft. business office in Navi Mumbai’s Business Park and an owned manufacturing plant in the Phalghar district. Our facilities meet the highest international standards, with EU GMP‑approved plants for solid dosage and oral liquids, and a WHO GMP‑approved API manufacturing site. - 60% with founders, and 40%with angel investors.
- Zero debt company.